Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis

Drug repurposing is the finding new activity of the existing drug. Recently, Albendazole’s well-known antihelmintic has got the attention of an anticancer drug. Plausible evidence of the interaction of Albendazole with one of the types of tyrosine kinase protein receptor, vascular endothelial growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaikwad, Nikita Maruti, Chaudhari, Pravin Digambar, Shaikh, Karimunnisa Sameer, Chaudhari, Somdatta Yashwant, Saleem, Rasha Mohammed, Algahtani, Mohammad, Altyar, Ahmed E., Albadrani, Ghadeer M., Kamel, Mohamed, Abdel-Daim, Mohamed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Formal Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431642/
https://www.ncbi.nlm.nih.gov/pubmed/37585409
http://dx.doi.org/10.1371/journal.pone.0287198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431642/
https://www.ncbi.nlm.nih.gov/pubmed/37585409
http://dx.doi.org/10.1371/journal.pone.0287198

Ejemplares similares